Amgen Inc diagnostics interface makes it easy to digest most current publicly released information about Amgen as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Amgen price relationship with some important fundamental indicators such as market cap and management efficiency.
About 82.0% of the company shares are held by institutions such as insurance companies. Book value of Amgen Inc was presently as 44.36. The company recorded earning per share (EPS) of 11.07. Amgen Inc last dividend was issued on 2018-02-14. This company had 2:1 split on 1999-11-22. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. For more info on AMGEN please contact Robert Bradway at 805 447-1010 or go to www.amgen.com.
Amgen Inc Alerts
Amgen Inc has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Over 82.0% of the company shares are held by institutions such as insurance companies
Financial Statements and Exhibits. Other Events. Entry into a Material Definitive Agreement
Schwab Charles Investment Management Inc
Bank Of Montreal
National Pension Service
Gateway Investment Advisers Llc
Nisa Investment Advisors Llc
Gulf International Bank Uk Ltd
Davenport Co Llc
The company currently falls under 'Mega-Cap' category with current market capitalization of 136.48 B.
The company has Profit Margin (PM) of 35.54 % which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 43.66 % which suggests for every 100 dollars of sales it generated a net operating income of 0.44.
Amgen Inc has return on total asset (ROA) of 7.92 % which means that it generated profit of $7.92 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 25.96 % meaning that it created $25.96 on every $100 dollars invested by stockholders.
Amgen Inc shows Mean Deviation of 0.6816 and Risk Adjusted Performance of 0.1818. Amgen Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm future prices. In plain English you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum or the prices will eventually revert. We found eighteen technical drivers for Amgen Inc which can be compared to its rivals. Please confirm Amgen IncVariance as well as the relationship between Maximum Drawdown and Semi Variance to decide if Amgen Inc is priced correctly providing market reflects its regular price of 188.01 per share. Given that Amgen has Treynor Ratio of 0.3381, we suggest you validate Amgen Inc prevailing market performance to make sure the company can sustain itself at future point.
Amgen Inc Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Amgen middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Amgen Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.